Download a discussion guide to bring to your physician.
This sheet was created to help you talk to your doctor about your treatment options.Download Now
Aside from skin cancer, prostate cancer is the most common cancer diagnosed in American men, with more than 288,000 estimated new cases diagnosed in 2023.1 In fact, about one man in eight will be diagnosed with prostate cancer in his lifetime.1
Prostate cancer occurs in the prostate, a small walnut-shaped gland in men that produces the seminal fluid that supplies sperm.1
Most prostate cancers are found early as a result of screening. Early prostate cancer usually causes no symptoms. More advanced prostate cancer sometimes cause symptoms, such as:3
• Problems urinating, including a slow or weak urinary stream or the need to urinate more often, especially at night
• Blood in the urine or semen
• Trouble getting an erection (erectile dysfunction or ED)
• Pain in the hips, back (spine), chest (ribs) or other areas from cancer that has spread to bones
• Weakness or numbness in the legs or feet, or even loss of bladder or bowel control from cancer pressing on the spinal cord
The symptoms above may be caused by something other than prostate cancer, such as Benign Prostatic Hyperplasia (BPH).3 Learn more about BPH, or an enlarged prostate.
Men are encouraged to talk to their healthcare provider if they have any of these symptoms.
If you have been diagnosed, it’s important to discuss treatment options with a doctor so you can make a decision that best fits your needs. Some factors men may wish to consider are:
• Stage and grade of cancer
• Other serious health conditions
• Possible side effects from each treatment
1. Key Statistics for Prostate Cancer. American Cancer Society. https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html. Accessed May 30, 2023.
2. Survival Rates for Prostate Cancer. American Cancer Society. https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/survival-rates.html. Accessed May 30, 2023.
3. Signs and Symptoms of Prostate Cancer. American Cancer Society. https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/signs-symptoms.html. Accessed May 30, 2023.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.
SpaceOAR Hydrogel is intended to temporarily move the rectal wall away from the prostate during the course of radiotherapy treatment for prostate cancer, and in creating this space it is the intent of SpaceOAR Hydrogel to reduce the radiation dose affecting the rectum.
SpaceOAR Hydrogel contains polyethylene glycol (PEG). As with any medical treatment, there are some risks involved with the use of SpaceOAR Hydrogel. Potential complications associated with SpaceOAR Hydrogel include, but are not limited to: pain associated with injection, pain or discomfort from the hydrogel, site inflammation, infection (including abscess), inability to urinate, urgent need to urinate, constipation, rectal muscle spasm, damage to lining of rectum, ulcers, fistula (a hole between rectum and bladder, urethra, or skin below the scrotum), perforation (hole in prostate, bladder, urethra, rectum), necrosis (dead tissue), allergic reaction (local reaction or more severe reaction, such as anaphylaxis), embolism (blood vessel blockage is possible and may happen outside of the pelvis, potentially impacting vital organs or legs), fainting, and bleeding. Please talk to your doctor about the risks and benefits related to using SpaceOAR Hydrogel. If one or more of these complications occur, you may need medical treatment or surgery. URO-1288805-AA
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.
© 2023 Boston Scientific Corporation or its affiliates. All rights reserved. URO-747207-AB JULY 2023